14
Search AOL Mail
AOL Mail
Menu
| Weather Weather
300

SearchResults

1 - 12 out of359 results
  • Putting Cash to Work(01:01)
  • Some widely held stocks have dropped 10% in the past 24 hours. Portfolio Manager David Peltier discussed what he's buying.
  • Date: October 10, 2013
  • Source: The Street
  • A Discounted Wide Moat in Biotech(01:49)
  • With an improving pipeline and a new manufacturing technology, Amgen is on the path to stabilizing its moat trend.
  • Date: January 21, 2015
  • Source: Morningstar.com
  • New Biotech ETFs Offer Exposure to Smaller...(02:26)
  • The new BioShares exchange traded funds offer exposure into small and mid-sized biotech stocks in what portends to be a big year in the sector, said A...
  • Date: January 07, 2015
  • Source: The Street
  • When to Buy a Stock to Receive the Dividen...(02:19)
  • David Peltier, Portfolio Manager of the Dividend Stock Advisor newsletter, helps investors figure out when to buy a stock in order to receive a divide...
  • Date: January 28, 2015
  • Source: The Street
  • What Impact Will a Rising Dollar Have on D...(05:37)
  • More than likely, it will mean smaller-than-usual dividend increases from companies with global footprints, says Morningstar's Josh Peters.
  • Date: January 23, 2015
  • Source: Morningstar.com
  • European Stocks Gain on Rise in German Inv...(01:37)
  • European markets rose on Tuesday as investors welcomed news of a climb in German investor confidence. In Copenhagen, Novozymes A/S rose after the Dani...
  • Date: January 20, 2015
  • Source: The Street
  • Dividend Outlook for 2015(07:15)
  • Repeating a stellar 2014 will be tough for REITs and utilities, while some higher-yielding multinational firms are much more attractive today, says th...
  • Date: January 16, 2015
  • Source: Morningstar.com
  • Dividend Lessons From the Last Decade(07:28)
  • As Morningstar Dividend Investor turns 10, editor Josh Peters looks back at how his portfolios have performed and what he has learned.
  • Date: January 09, 2015
  • Source: Morningstar.com
  • Regeneron: A Biotech With a Growing Moat(01:20)
  • Regeneron's moat is widening thanks to recent clinical successes and a productive pipeline; however, investors should wait for a better price before b...
  • Date: December 31, 2014
  • Source: Morningstar.com
  • Biotech Selloff Causes Nasdaq to Drop Over...(03:10)
  • The volatile biotech sector is experiencing extreme selling on Friday, pushing the NASDAQ down over two percent. Sr. Biotech Editor Adam Feuerstein sa...
  • Date: April 04, 2014
  • Source: The Street
  • Stocks Extend Holiday Cheer, Gilead Scienc...(01:18)
  • On the last Friday of the year, December 26, major U.S. indexes wrapped up the second straight week in record territory. Previously beaten down biotec...
  • Date: December 28, 2014
  • Source: The Street
  • Celgene and Gilead Pressure Nasdaq Lower a...(00:57)
  • Stocks extended their rally in midday trading Tuesday for the most part. The Dow industrials are shooting past 18,000. The S&P 500 is at its intraday ...
  • Date: December 23, 2014
  • Source: The Street

123456789101112